Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash from Financing Activities: 2018-2019

Historic Cash from Financing Activities for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to -$1,000.

  • DiaMedica Therapeutics' Cash from Financing Activities fell 100.01% to -$1,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $70,000, marking a year-over-year decrease of 99.67%. This contributed to the annual value of $12.0 million for FY2024, which is 67.44% down from last year.
  • DiaMedica Therapeutics' Cash from Financing Activities amounted to -$1,000 in Q4 2019, which was down 0.00% from -$1,000 recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Cash from Financing Activities registered a high of $14.8 million during Q4 2018, and its lowest value of -$2,000 during Q1 2019.
  • Over the past 2 years, DiaMedica Therapeutics' median Cash from Financing Activities value was $40,000 (recorded in 2018), while the average stood at $2.7 million.
  • Examining YoY changes over the last 5 years, DiaMedica Therapeutics' Cash from Financing Activities showed a top increase of 51.02% in 2019 and a maximum decrease of 103.23% in 2019.
  • Quarterly analysis of 2 years shows DiaMedica Therapeutics' Cash from Financing Activities stood at $14.8 million in 2018, then crashed by 100.01% to -$1,000 in 2019.
  • Its last three reported values are -$1,000 in Q4 2019, -$1,000 for Q3 2019, and $74,000 during Q2 2019.